Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 5.75 | 22.49 | 18.32 | 11.44 |
Cash Equivalents | 8.08 | - | - | - |
Short Term Investments | 139.43 | 91.35 | 96.96 | 80.75 |
Cashand Short Term Investments | 153.26 | 113.85 | 115.28 | 92.19 |
Accounts Receivable- Trade Net | 161.77 | 136.47 | 116.28 | 111.53 |
Total Receivables Net | 200.21 | 170.82 | 163.41 | 146.44 |
Total Inventory | 77.17 | 70.03 | 72.74 | 46.61 |
Other Current Assets Total | 16.11 | 12.34 | 0.49 | 20.08 |
Total Current Assets | 446.74 | 367.21 | 352.85 | 306.46 |
Property/ Plant/ Equipment Total- Net | 182.48 | 156.95 | 147.55 | 111.93 |
Intangibles Net | 0.33 | 0.29 | 0.38 | 0.40 |
Long Term Investments | 0.61 | 0.48 | 1.75 | 0.54 |
Note Receivable- Long Term | 65.76 | 60.13 | 27.66 | 25.76 |
Other Long Term Assets Total | 4.37 | 2.36 | 4.17 | 5.07 |
Total Assets | 700.29 | 587.42 | 534.36 | 459.37 |
Accounts Payable | 72.44 | 51.15 | 71.66 | 56.79 |
Notes Payable/ Short Term Debt | 1.07 | 2.00 | 2.04 | 0.00 |
Other Currentliabilities Total | 18.77 | 13.01 | 10.90 | 11.69 |
Total Current Liabilities | 92.28 | 72.28 | 90.49 | 73.55 |
Long Term Debt | 0.00 | 0.00 | 0.00 | - |
Total Long Term Debt | 0.00 | 0.00 | 0.00 | 0.14 |
Total Debt | 1.07 | 2.00 | 2.04 | 0.52 |
Deferred Income Tax | 11.46 | 7.94 | 6.45 | 5.69 |
Other Liabilities Total | 3.72 | 4.72 | 4.54 | 4.29 |
Total Liabilities | 107.45 | 84.95 | 101.48 | 84.08 |
Common Stock Total | 20.03 | 20.03 | 20.03 | 20.00 |
Retained Earnings( Accumulated Deficit) | 572.81 | 418.31 | 348.41 | 290.98 |
Total Equity | 592.84 | 502.47 | 432.88 | 375.29 |
Total Liabilities Shareholders' Equity | 700.29 | 587.42 | 534.36 | 459.37 |
Total Common Shares Outstanding | 2.00 | 2.00 | 2.00 | 2.00 |
Tangible Book Valueper Share Common Eq | 295.82 | 250.72 | 215.93 | 182.83 |
Prepaid Expenses | - | 0.18 | 0.93 | 1.14 |
Property/ Plant/ Equipment Total- Gross | - | 202.96 | 185.94 | 142.69 |
Accumulated Depreciation Total | - | -46.01 | -38.39 | -30.76 |
Accrued Expenses | - | 6.13 | 5.88 | 4.69 |
Additional Paid- In Capital | - | 64.62 | 64.62 | 64.62 |
Other Equity Total | - | -0.48 | -0.18 | -0.31 |
Goodwill Net | - | - | - | 9.23 |
Current Portof LT Debt/ Capital Leases | - | - | - | 0.38 |
Capital Lease Obligations | - | - | - | 0.14 |
Minority Interest | - | - | - | 0.41 |
Lincoln Pharmaceuticals Dividend Lincoln Pharmaceuticals Bonus Lincoln Pharmaceuticals News Lincoln Pharmaceuticals AGM Lincoln Pharmaceuticals Rights Lincoln Pharmaceuticals Splits Lincoln Pharmaceuticals Board Meetings Lincoln Pharmaceuticals Key Metrics Lincoln Pharmaceuticals Shareholdings Lincoln Pharmaceuticals Profit Loss Lincoln Pharmaceuticals Cashflow Lincoln Pharmaceuticals Q1 Results Lincoln Pharmaceuticals Q2 Results Lincoln Pharmaceuticals Q3 Results Lincoln Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks